FreeGuest Editorial Learning from suramin: A case study of NCI’s much-hyped cancer drug that crashed and burned—35 years ago August 09, 2019Vol.45 No.32By Cy Stein
Conversation with The Cancer LetterFree Indiana University Simon Cancer Center becomes 51st NCI-designated comprehensive cancer center August 06, 2019Vol.45 No.32By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Sylvester becomes 71st NCI-designated cancer center July 29, 2019Vol.45 No.31By Paul Goldberg
Conversation with The Cancer LetterFree UToronto researchers: Women with cervical cancer had poorer outcomes with minimally invasive surgery July 19, 2019Vol.45 No.29By Matthew Bin Han Ong
Free Ontario study: Women undergoing minimally invasive procedures for early-stage cervical cancer had double the rates of death, recurrence July 19, 2019Vol.45 No.29By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Curtis: Women are intrigued by the many questions asked in TMIST July 12, 2019Vol.45 No.28By Paul Goldberg
FreeFunding Opportunities Why cancer innovation must go beyond medicine:The C3 Prize search for ideas with the greatest potential for impact July 12, 2019Vol.45 No.28By Mark Reisenauer
Film & TVFree Chernobyl, the HBO miniseries: Fact and fiction (Part IV) June 21, 2019Vol.45 No.25By Robert Peter Gale
Free How a Flatiron hackathon team linked Medicaid expansion with reduction in racial disparities in time to cancer treatment June 21, 2019Vol.45 No.25By Matthew Bin Han Ong